Amplify Weight Loss Drug & Treatment ETF (THNR) Chart & Stock Price History $22.76 -0.08 (-0.35%) As of 08/28/2025 04:10 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Stock Price Performance The Amplify Weight Loss Drug & Treatment ETF (THNR) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has decreased 18.60%, with a year-to-date return of 0.93%. In the past month, the fund has decreased 1.51%, reflecting recent market activity. As of the latest close, Amplify Weight Loss Drug & Treatment ETF traded at $22.76 with a market cap of $2.96 million and volume of 580 shares. Receive THNR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-1.68%1 Month Performance-1.51%3 Month Performance+3.83%Year-To-Date Performance+0.93%1 Year Performance-18.60% THNR Stock Chart for Friday, August, 29, 2025 THNR Chart by TradingView Amplify Weight Loss Drug & Treatment ETF Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/28/2025$22.84$22.76-0.35%$23.12$22.76580 shs$2.96 million08/27/2025$22.91$22.84-0.31%$22.90$22.80540 shs$2.97 million08/26/2025$22.87$22.91+0.17%$22.91$22.711,522 shs$2.98 million08/25/2025$23.15$22.87-1.21%$22.91$22.871,170 shs$2.97 million08/22/2025$22.99$23.15+0.70%$23.31$23.152,284 shs$3.01 million08/21/2025$22.96$22.99+0.13%$23.24$22.991,836 shs$2.99 million08/20/2025$22.80$22.96+0.70%$22.96$22.84482 shs$2.99 million08/19/2025$23.08$22.80-1.21%$22.92$22.80378 shs$2.96 million08/18/2025$22.94$23.08+0.61%$23.27$23.003,078 shs$3 million08/15/2025$22.55$22.94+1.73%$23.00$22.743,467 shs$2.98 million Get the Latest News and Ratings for THNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. 08/14/2025$22.50$22.55+0.22%$22.55$22.445,062 shs$2.93 million08/13/2025$21.98$22.50+2.37%$22.59$22.331,218 shs$2.93 million08/12/2025$22.00$21.98-0.09%$22.05$21.961,011 shs$2.86 million08/11/2025$21.99$22.00+0.05%$22.17$21.994,150 shs$2.86 million08/08/2025$21.91$21.99+0.37%$22.13$21.99836 shs$2.86 million08/07/2025$22.28$21.91-1.66%$21.97$21.7040,733 shs$2.85 million08/06/2025$22.80$22.28-2.28%$22.99$22.232,651 shs$2.90 million08/05/2025$22.85$22.80-0.22%$22.81$22.791,304 shs$2.96 million08/04/2025$22.58$22.85+1.20%$22.86$22.612,197 shs$2.97 million08/01/2025$22.45$22.58+0.58%$22.58$22.451,303 shs$2.94 million07/31/2025$22.92$22.45-2.05%$22.90$22.45736 shs$2.92 million07/30/2025$23.11$22.92-0.82%$23.15$22.921,147 shs$2.98 million07/29/2025$23.64$23.11-2.24%$23.65$22.8422,633 shs$3.00 million07/28/2025$23.85$23.64-0.88%$24.02$23.641,059 shs$3.07 million Related Companies iShares Health Innovation Active ETF Stock Chart NYLI Clean Oceans ETF Stock Chart SmartETFs Sustainable Energy II ETF Stock Chart KraneShares 90% KWEB Defined Outcome Through January 2026 ETF Stock Chart Grayscale Bitcoin Adopters ETF Stock Chart Global X Interest Rate Hedge ETF Stock Chart iShares Emergent Food and AgTech Multisector ETF Stock Chart ProShares Nanotechnology ETF Stock Chart ProShares Ultra Nasdaq Cybersecurity ETF Stock Chart Fidelity Women's Leadership ETF Stock Chart Receive THNR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:THNR) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access